comparemela.com

Latest Breaking News On - Robertj coury - Page 7 : comparemela.com

Biocon Biologics to Acquire Viatris Biosimilars Assets for up to USD 3 335 billion in Stock and Cash

/PRNewswire/ Biocon Biologics Ltd., a subsidiary of Biocon Ltd. (BSE code: 532523) (NSE: BIOCON), has entered into a definitive agreement with its partner.

Mylan completes acquisition of Merck s generic unit

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.